To examine whether HCRP-1 mediated up-regulation of the ERK pathway is EGFR dependent, RCC cells 786-O and OS-RC-2 transfected with siRNA for HCRP-1 were treated with the EGFR inhibitor, AG1478 (1 nmol/L). Here, EGFR is linked to renal cell carcinoma.